Screening and identification of the nucleic acid aptamers in nasopharyngeal carcinoma

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 6850-6857

  Chen, W X ^a,b   Zhang, K H ^b   Zou, X S ^a   Chen, Y Q ^a   Li, J G ^a  

^a NANCHANG UNIVERSITY   (China)

^b Tumor Hospital of Jiangxi Province   (China)

Author keywords

Aptamer; Nasopharyngeal carcinoma; SELEX

Indexed keywords

APTAMER; DNA; NUCLEIC ACID; NUCLEOTIDE;

ARTICLE; BINDING AFFINITY; CARCINOMA CELL; CELL DIFFERENTIATION; CLUSTER ANALYSIS; COMBINATORIAL CHEMISTRY; DNA LIBRARY; DNA SCREENING; EPITHELIUM CELL; EPSTEIN BARR VIRUS; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEIC ACID ANALYSIS; NUCLEIC ACID SYNTHESIS; NUCLEOTIDE SEQUENCE; PROTEIN FAMILY; SEQUENCE ANALYSIS; TARGET CELL;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CELL LINE, TUMOR; EPSTEIN-BARR VIRUS INFECTIONS; GENE LIBRARY; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; SELEX APTAMER TECHNIQUE; SEQUENCE ANALYSIS, DNA;

EID: 84891081077     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.December.19.3     Document Type: Article

References (13)

1. Cerchia L, Giangrande PH, McNamara JO and de Francisco V (2009). Cell-specific aptamers for targeted therapies. Methods Mol. Biol. 535: 59-78.
2. Chen HW, Medley CD, Sefah K, Shangguan D, et al. (2008). Molecular recognition of small-cell lung cancer cells using aptamers. Chem. Med. Chem. 3: 991-1001.
3. Ellington AD and Szostak JW (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
4. Fang X and Tan W (2010). Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc. Chem. Res. 43: 48-57.
5. Faria M and Ulrich H (2002). The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Curr. Cancer Drug Targets 2: 355-368.
6. Fitzwater T and Polisky B (1996). A SELEX primer. Methods Enzymol. 267: 275-301.
7. Gold L (1995). Oligonucleotides as research, diagnostic, and therapeutic agents. J. Biol. Chem. 270: 13581-13584.
8. Gopinath SC (2007). Methods developed for SELEX. Anal. Bioanal. Chem. 387: 171-182.
9. Hess GP, Ulrich H, Breitinger HG, Niu L, et al. (2000). Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801. Proc. Natl. Acad. Sci. U. S. A. 97: 13895-13900.
10. Jayasena SD (1999). Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 45: 1628-1650.
11. Shangguan D, Li Y, Tang Z, Cao ZC, et al. (2006). Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. U. S. A. 103: 11838-11843.
12. Tuerk C and Gold L (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
13. Ulrich H, Martins AH and Pesquero JB (2004). RNA and DNA aptamers in cytomics analysis. Cytometry A 59: 220-231.